Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts
Open accessThe DOI matches its Crossref record.
Abstract
Myofibroblasts play an essential role in the abnormal deposition of extracellular matrix in pulmonary fibrosis. The presence or prolonged survival of these cells may be a key factor in the pathogenesis of progressive pulmonary fibrosis. Found in inflammatory zone (FIZZ)1 can induce myofibroblast differentiation and has an antiapoptotic effect on embryonic lung explant cultures. In this study, we investigated whether FIZZ1 also has an antiapoptotic effect on mouse lung fibroblasts (MLFs). Cells were treated with FIZZ1 for 24 h and then apoptosis was induced by TNFα in the presence of cycloheximide (CHX). FIZZ1 exhibited an antiapoptotic effect in MLFs, as assessed by flow cytometric analysis and TUNEL staining. Moreover, the cell number was higher in the FIZZ1‐treated group relative to the non‐treated control group after treatment with TNFα and CHX. FIZZ1 treatment also inhibited the apoptotic agent‐induced activities of caspase‐3 and caspase‐8. Examination of potential signalling pathways revealed that FIZZ1 induced rapid phosphorylation of ERK‐1/2, while PD98059, a MEK/ERK inhibitor, markedly induced activation of caspase‐3. This anti‐apoptotic effect of FIZZ1 was associated with induction of myofibroblast differentiation in response to FIZZ1 stimulation. Taken together, these findings suggest that FIZZ1 is involved in pulmonary fibrosis through both induction of myofibroblast differentiation and increased or prolonged survival of myofibroblasts. This effect of FIZZ1 was mediated by inhibition of caspase‐3 and ‐8, with involvement of the ERK pathway. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
Sakai, & Tager, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.001 · Cited by 285
Retnla (Relmα/Fizz1) Suppresses Helminth-Induced Th2-Type Immunity
Pesce, J. T., Ramalingam, T. R., Wilson, M. S., Mentink-Kane, M. M., Thompson, R. W., Cheever, A. W., Urban, J. F., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000393 · Cited by 213
“Retnla modulation of fibrosis was particularly unexpected, as numerous recent reports indicated that Retnla might be important for the development of fibrosis [23,25,29,50].”
ResultThe in vivo fibrotic role of FIZZ1 in pulmonary fibrosis
Liu, T., Yu, H., Ullenbruch, M., Jin, H., Ito, T., Wu, Z., Liu, J., & Phan, S. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088362 · Cited by 62
Self-citation
Metadata
- Authors
- Chung, M., Liu, T., Ullenbruch, M., & Phan, S.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2007-05-11
- Volume
- 212
- Issue
- 2
- Pages
- 180-187
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2052740748
- Cited by
- 37
- References
- 0
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.